Rodney S Markin
CIK 1393415 · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$25.4K
Companies
4
Total Filings
31
Lifetime Open-Market Net
$130.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRDF | Director | 31,060 | $0.82 | $25.4K | $59.9K | 9 | 2026-06-15 |
| Cardiff Oncology, Inc. (TROV) Delisted | Director | 43,085 | — | — | $70.0K | 7 | 2019-06-24 |
| Cardiff Oncology, Inc. (TROVW) Delisted | Director | — | — | — | $0 | 6 | 2017-01-05 |
| Precipio, Inc. (TBIO) Delisted | Director | 0 | $0.00 | $0 | $0 | 9 | 2014-02-20 |
Recent Filings · Page 2 of 4
31 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-11-09 | Cardiff Oncology, Inc. (TROV) Delisted | Buy (P) | +41,200 | $35.0K | EDGAR |
| 2018-06-21 | Cardiff Oncology, Inc. (TROV) Delisted | Buy (P) | +41,200 | $35.0K | EDGAR |
| 2018-01-25 | Cardiff Oncology, Inc. (TROV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-04 | Cardiff Oncology, Inc. (TROV) Delisted | Exer (M) | +16,667 | $0 | EDGAR |
| 2017-10-05 | Cardiff Oncology, Inc. (TROV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-06 | Cardiff Oncology, Inc. (TROV) Delisted | Exer (M) | +5,943 | $0 | EDGAR |
| 2017-01-05 | Cardiff Oncology, Inc. (TROVW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-04 | Cardiff Oncology, Inc. (TROVW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-06 | Cardiff Oncology, Inc. (TROVW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-19 | Cardiff Oncology, Inc. (TROVW) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.